Practice guidelines for sedation and analgesia management of critically ill children: a pilot study evaluating guideline impact and feasibility in the PICU

被引:32
作者
Keogh, Samantha J. [1 ,3 ]
Long, Debbie A. [2 ,3 ]
Horn, Desley V. [2 ]
机构
[1] Royal Childrens Hosp, Nursing Res Serv, Brisbane, Qld, Australia
[2] Royal Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia
[3] Griffith Univ, Griffith Hlth Inst, Ctr Hlth Practice Innovat, NHMRC Ctr Res Excellence Nursing NCREN, Nathan, Qld 4111, Australia
关键词
PEDIATRIC INTENSIVE-CARE; MECHANICAL VENTILATION; CLINICAL-PRACTICE; MULTIDIMENSIONAL ASSESSMENT; NEUROMUSCULAR BLOCKADE; WITHDRAWAL SYNDROME; PAIN SCALE; UNIT; ADHERENCE; PROTOCOL;
D O I
10.1136/bmjopen-2014-006428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The aim of this study was to develop and implement guidelines for sedation and analgesia management in the paediatric intensive care unit (PICU) and evaluate the impact, feasibility and acceptability of these as part of a programme of research in this area and as a prelude to future trial work. Method: This pilot study used a pre-post design using a historical control. Setting: Two PICUs at different hospitals in an Australian metropolitan city. Participants: Patients admitted to the PICU and ventilated for >= 24 h, aged more than 1 month and not admitted for seizure management or terminal care. Intervention: Guidelines for sedation and analgesia management for critically ill children including algorithm and assessment tools. Outcome variables: In addition to key outcome variables (ventilation time, medication dose and duration, length of stay), feasibility outcomes data (recruitment, data collection, safety) were evaluated. Guideline adherence was assessed through chart audit and staff were surveyed about merit and the use of guidelines. Results: The guidelines were trialled for a total of 12 months on 63 patients and variables compared with the historical control group (n=75). Analysis revealed differences in median Morphine infusion duration between groups (pretest 3.63 days (87 h) vs post-test 2.83 days (68 h), p=0.05) and maximum doses (pretest 120 mu g/kg/h vs post-test 97.5 mu g/kg/h) with no apparent change to ventilation duration. Chart audit revealed varied use of tools, but staff were positive about the guidelines and their use in practice. Conclusions: The sedation guidelines impacted on the duration and dosage of agents without any apparent impact on ventilation duration or length of stay. Furthermore, the guidelines appeared to be feasible and acceptable in clinical practice. The results of the study have laid the foundation for follow-up studies in withdrawal from sedation, point prevalence and longitudinal studies of sedation practices as well as drug trial work.
引用
收藏
页数:9
相关论文
共 58 条
[51]   PIM2: a revised version of the Paediatric Index of Mortality [J].
Slater, A ;
Shann, F ;
Pearson, G .
INTENSIVE CARE MEDICINE, 2003, 29 (02) :278-285
[52]   Developmental care for promoting development and preventing morbidity in preterm infants [J].
Symington, A. ;
Pinelli, J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)
[53]   Sedation and analgesia in paediatric intensive care units: A guide to drug selection and use [J].
Tobias J.D. .
Pediatric Drugs, 1999, 1 (2) :109-126
[54]   Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit [J].
Tobias, JD .
CRITICAL CARE MEDICINE, 2000, 28 (06) :2122-2132
[55]   OUTPATIENT THERAPY OF IATROGENIC DRUG DEPENDENCY FOLLOWING PROLONGED SEDATION IN THE PEDIATRIC INTENSIVE-CARE UNIT [J].
TOBIAS, JD ;
DESHPANDE, JK ;
GREGORY, DF .
INTENSIVE CARE MEDICINE, 1994, 20 (07) :504-507
[56]  
Twite Mark D, 2004, Pediatr Crit Care Med, V5, P521, DOI 10.1097/01.PCC.0000144710.13710.2E
[57]   Optimal sedation in pediatric intensive care patients: a systematic review [J].
Vet, Nienke J. ;
Ista, Erwin ;
de Wildt, Saskia N. ;
van Dijk, Monique ;
Tibboel, Dick ;
de Hoog, Matthijs .
INTENSIVE CARE MEDICINE, 2013, 39 (09) :1524-1534
[58]  
Vickers A., 2004, Cochrane Database of Systematic Reviews, DOI [10.1002/14651858. CD000390.pub2, DOI 10.1002/14651858.CD000390.PUB2, 10.1002/14651858.CD000390]